Natco Pharma to Incorporate Wholly Owned Subsidiary in Chile with $300,000 Investment

Natco Pharma Ltd. has announced its decision to incorporate a wholly owned subsidiary in Chile, named NATCO Pharma Chile SPA, with an investment of up to $300,000. The new subsidiary will be engaged in the pharmaceuticals industry, in line with the holding company's primary business. The decision was approved at a Board of Directors meeting, with the new entity expected to comply with all necessary FEMA regulations and regulatory approvals in Chile.